ARK Genomic Revolution ETF

Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You

Benzinga•28d ago

Beyond Cellular Models: Longevica Capitalizes on World's Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline

Business Wire•28d ago

3 Analysts, 3 Trades to Make Today

InvestorPlace•1mo ago

Cathie Wood's Ark Has Delivered Just a 13.8% Annualized Return Since 2014, Roughly Matching the S&P 500. Should You Trust Her Bold Predictions for 2030?

Fool - Investing News•1mo ago

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Benzinga•1mo ago

Best-Performing ETF Areas of August

Zacks Investment Research•1mo ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Fool - Investing News•1mo ago

ARKG: Caught In The Tech Sell-Off, But Here's Why The Dip Is Buyable

Seeking Alpha•2mo ago